EHA Annual Meeting: Statements from Dr. Koffman

You are here:

Home
Conference Coverage
2019 Conferences
EHA Annual Meeting: Statements from Dr. Koffman

For a chance to hear Dr. Koffman’s opinions on 6 quick topics, visit here.

About the author

Brad Hedrick

Related posts

ASH 2019: Dr. John Allan on Richter’s Transformation in CLL (chronic lymphocytic leukemia)
January 19, 2020

ASH 2019: Dr. Brian Koffman Interviewed by Zack Pemberton-Whiteley, Leukaemia Care, UK
January 19, 2020

iwCLL 2019: Dr. Jan Burger on targeting the B cell receptor (BCR) in chronic lymphocytic leukemia (CLL)
January 6, 2020

iwCLL 2019: Dr. Danielle Brander on Bendamustine and Rituxan (BR) versus Ibrutinib Based Therapies for Frontline Treatment of Chronic Lymphocytic Leukemia (CLL) in Elderly Patients
January 2, 2020

ASCO 2019: Pick #1 RESONATE: 6 year follow-up in previously treated CLL (chronic lymphocytic leukemia) on ibrutinib
December 24, 2019

ASCO 2019: Pick #2 Fixed duration Venetoclax + Obinutuzumab in untreated CLL (chronic lymphocytic leukemia)
December 24, 2019

Social media & sharing icons powered by UltimatelySocial